E-LIB Suche - Ergebnisse für: Le Lay, K.

1

HTA24 Adopting a Societal Perspective in Health-Economic Ev..:

Gerves-Pinquie, C. ; Nanoux, H ; Borget, I...
Value in Health. 27 (2024) 6 - p. S248 , 2024

Link: https://doi.org/10.1016/..

2

EE259 The Societal Cost of Age-Related Macular Degeneration..:

Gerves-Pinquie, C. ; Roula, A. ; Hidra, R....
Value in Health. 26 (2023) 12 - p. S101 , 2023

Link: https://doi.org/10.1016/..

3

EE223 Estimation of the T-Cell Engagers (Bi-Specific Monocl..:

Le Dissez, C. ; Le Lay, K. ; Cartron, G....
Value in Health. 26 (2023) 12 - p. S94 , 2023

Link: https://doi.org/10.1016/..

4

EE241 Budget Impact of Making Emicizumab Available at the C..:

Leleu, H. ; Fraticelli, L. ; Roula, A....
Value in Health. 26 (2023) 12 - p. S97 , 2023

Link: https://doi.org/10.1016/..

5

HSD63 New Pathway in Anti-HER2 Treatments' Administration i..:

Pozzar, M. ; Couillerot, A.L. ; Gherardi, A....
Value in Health. 26 (2023) 12 - p. S305-S306 , 2023

Link: https://doi.org/10.1016/..

6

EPH165 Assessing Public Health Models in France: A Systemat..:

Moreau, R. ; Massetti, M. ; Roula, A....
Value in Health. 26 (2023) 12 - p. S234 , 2023

Link: https://doi.org/10.1016/..

7

EE629 Methodological Concerns in the Medico-Economic Modeli..:

Chamielec, C ; Le Lay, K ; Sambuc, C.
Value in Health. 25 (2022) 12 - p. S179-S180 , 2022

Link: https://doi.org/10.1016/..

8

EPH64 Public Health Impact of COVID-19 in French Ambulatory..:

Supiot, R ; Millier, A ; Benyounes, K...
Value in Health. 25 (2022) 12 - p. S203 , 2022

Link: https://doi.org/10.1016/..

9

EE102 Economic and Organisational Impact of an Innovative T..:

Bourel, G ; Monnier, R ; Ba, S...
Value in Health. 25 (2022) 12 - p. S73 , 2022

Link: https://doi.org/10.1016/..

10

EE36 Impact of Home Hospitalization on the Cost of Care for..:

Benyounes, K ; Le Lay, K ; Roula, A...
Value in Health. 25 (2022) 12 - p. S59-S60 , 2022

Link: https://doi.org/10.1016/..

11

EPH4 Burden and Characteristics of COVID-19 in France Durin..:

Leboucher, C ; Blein, C ; Machuron, V...
Value in Health. 25 (2022) 12 - p. S191 , 2022

Link: https://doi.org/10.1016/..

12

EE173 Cost-Effectiveness of Risdiplam for Patients with Typ..:

Boussahoua, M ; Sutherland, CS ; Aponte Ribero, V...
Value in Health. 25 (2022) 12 - p. S87 , 2022

Link: https://doi.org/10.1016/..

13

EE426 Budget Impact Analysis of Atezolizumab in 1ST Line Tr..:

Benyounes, K ; Delzard, M ; Le Lay, K..
Value in Health. 25 (2022) 12 - p. S139 , 2022

Link: https://doi.org/10.1016/..

14

EE324 Cost-Effectiveness analysis of Atezolizumab as Adjuva..:

Plessala, I ; Chouaid, C ; Souquet, PJ...
Value in Health. 25 (2022) 12 - p. S117-S118 , 2022

Link: https://doi.org/10.1016/..

15

PMS52 Quality of Life in Ssc-ILD Patients: Understanding th..:

Allanore, Y. ; Constans, J. ; Godard, D....
Value in Health. 23 (2020) - p. S601 , 2020

Link: https://doi.org/10.1016/..